Literature DB >> 22079988

Antigen targeting to plasmacytoid dendritic cells via Siglec-H inhibits Th cell-dependent autoimmunity.

Jakob Loschko1, Sylvia Heink, Daniela Hackl, Diana Dudziak, Wolfgang Reindl, Thomas Korn, Anne B Krug.   

Abstract

Plasmacytoid dendritic cells (PDCs) have been shown to present Ags and to contribute to peripheral immune tolerance and to Ag-specific adaptive immunity. However, modulation of adaptive immune responses by selective Ag targeting to PDCs with the aim of preventing autoimmunity has not been investigated. In the current study, we demonstrate that in vivo Ag delivery to murine PDCs via the specifically expressed surface molecule sialic acid binding Ig-like lectin H (Siglec-H) inhibits Th cell and Ab responses in the presence of strong immune stimulation in an Ag-specific manner. Correlating with sustained low-level MHC class II-restricted Ag presentation on PDCs, Siglec-H-mediated Ag delivery induced a hyporesponsive state in CD4(+) T cells leading to reduced expansion and Th1/Th17 cell polarization without conversion to Foxp3(+) regulatory T cells or deviation to Th2 or Tr1 cells. Siglec-H-mediated delivery of a T cell epitope derived from the autoantigen myelin oligodendrocyte glycoprotein to PDCs effectively delayed onset and reduced disease severity in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis by interfering with the priming phase without promoting the generation or expansion of myelin oligodendrocyte glycoprotein-specific Foxp3(+) regulatory T cells. We conclude that Ag delivery to PDCs can be harnessed to inhibit Ag-specific immune responses and prevent Th cell-dependent autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22079988     DOI: 10.4049/jimmunol.1102307

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  52 in total

1.  STALing B cell responses with CD22.

Authors:  Craig P Chappell; Edward A Clark
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

Review 2.  Clinical view on the importance of dendritic cells in asthma.

Authors:  Rohit Gaurav; Devendra K Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2013-10       Impact factor: 4.473

Review 3.  Controlling immune responses by targeting antigens to dendritic cell subsets and B cells.

Authors:  Craig P Chappell; Natalia V Giltiay; Christiane Dresch; Edward A Clark
Journal:  Int Immunol       Date:  2013-11-27       Impact factor: 4.823

Review 4.  Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccination.

Authors:  Cathleen Petzold; Sonja Schallenberg; Joel N H Stern; Karsten Kretschmer
Journal:  Rev Diabet Stud       Date:  2012-12-28

Review 5.  Dendritic cells: arbiters of immunity and immunological tolerance.

Authors:  Kanako L Lewis; Boris Reizis
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

Review 6.  Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions.

Authors:  Takumi Kiwamoto; Norihito Kawasaki; James C Paulson; Bruce S Bochner
Journal:  Pharmacol Ther       Date:  2012-06-27       Impact factor: 12.310

7.  Plasmacytoid dendritic cells cross-prime naive CD8 T cells by transferring antigen to conventional dendritic cells through exosomes.

Authors:  Chunmei Fu; Peng Peng; Jakob Loschko; Li Feng; Phuong Pham; Weiguo Cui; Kelvin P Lee; Anne B Krug; Aimin Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-02       Impact factor: 11.205

Review 8.  Sialic acid-binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses.

Authors:  Heinz Läubli; Ajit Varki
Journal:  Cell Mol Life Sci       Date:  2019-09-04       Impact factor: 9.261

9.  In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells.

Authors:  Marianna Ioannou; Themis Alissafi; Louis Boon; Dimitrios Boumpas; Panayotis Verginis
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

10.  Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis.

Authors:  Paul K Ziegler; Julia Bollrath; Charles K Pallangyo; Takaji Matsutani; Özge Canli; Tiago De Oliveira; Michaela A Diamanti; Nina Müller; Jaba Gamrekelashvili; Tracy Putoczki; David Horst; Arun K Mankan; Meryem G Öner; Susanna Müller; Josef Müller-Höcker; Thomas Kirchner; Julia Slotta-Huspenina; M Mark Taketo; Thomas Reinheckel; Stefan Dröse; Andrew C Larner; Winfried S Wels; Matthias Ernst; Tim F Greten; Melek C Arkan; Thomas Korn; Dagmar Wirth; Florian R Greten
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.